ALICIA BISPLINGHOFF: Open Payments
NPI 1811758642 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,889 in 102 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,054 · 2025 $1,889
Food & beverage: $1,889
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $350 |
| ABBVIE INC. | 12 | $275 |
| Novo Nordisk Inc | 11 | $196 |
| Amgen Inc. | 12 | $178 |
| Esperion Therapeutics, Inc. | 9 | $162 |
| GlaxoSmithKline, LLC. | 18 | $159 |
| SANOFI-AVENTIS U.S. LLC | 3 | $113 |
| Astellas Pharma US Inc | 5 | $113 |
| Lilly USA, LLC | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
Products named: NURTEC ODT, NEXLETOL, VRAYLAR, QULIPTA, TZIELD, Veozah, ELIQUIS, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
